Related Experiment Video
Updated: Jan 6, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Published on: June 8, 2014
Osteonecrosis of the jaw as a possible adverse effect of tocilizumab
Hedyeh Samady1, Mark Drangsholt2, Gale Sebastian3
1Department of Oral Medicine, University of Washington, Seattle, WA, USA.
Abstract:
We report the case of a 79-year-old female with a complex medical history, presenting with recurrent gingival swelling, progressive gingival hyperplasia, and osteonecrosis of the jaw potentially associated with tocilizumab. Oral complications developed in close proximity to diagnosis of chronic myelomonocytic leukemia, complicating diagnosis and management.
Related Concept Videos
Osteoclasts in Bone Remodeling
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Chronic Kidney Disease II: Clinical Manifestations
